Risk factors
HCW Biologics (HCWB) risk factors
Item 1A of every HCW Biologics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors45 risks1 new2 dropped8 reworded
Nasdaq listing compliance issues, ongoing going concern doubts, and significant past due liabilities dominate this company's risk profile.
Filed Mar 31, 2026 - FY2024 10-K risk factors46 risks
HCW Biologics faces going-concern doubts with significant historical losses and $17.8 million in past-due accounts payable. The company relies on a single third-party manufacturer for clinical supply and has no commercial products. Nasdaq listing compliance remains conditional under an accepted plan.
Filed Mar 28, 2025